Cancer studies explore targeted therapy, researchers seek new prevention strategies.
Stephenson
Joan
J
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000975:Antioxidants / Q000627:therapeutic use*; D001549:Benzamides; D001943:Breast Neoplasms / Q000235:genetics / Q000517:prevention & control*; D019008:Drug Resistance, Neoplasm; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D005260:Female; D019398:Genes, BRCA1; D024522:Genes, BRCA2; D006801:Humans; D000068877:Imatinib Mesylate; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy; D008175:Lung Neoplasms / Q000209:etiology* / Q000517:prevention & control*; D008297:Male; D008408:Mastectomy; D010051:Ovarian Neoplasms / Q000235:genetics / Q000517:prevention & control*; D010052:Ovariectomy; D010879:Piperazines / Q000627:therapeutic use*; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors; D011743:Pyrimidines / Q000627:therapeutic use*; D018168:Receptors, Retinoic Acid / Q000378:metabolism; D012907:Smoking / Q000009:adverse effects; D014028:Tobacco Smoke Pollution / Q000009:adverse effects; D014212:Tretinoin / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D014815:Vitamins / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D000975:Antioxidants; D001549:Benzamides; D004791:Enzyme Inhibitors; D010879:Piperazines; D011743:Pyrimidines; D018168:Receptors, Retinoic Acid; D014028:Tobacco Smoke Pollution; D014815:Vitamins; C082925:retinoic acid receptor beta; C105492:9,13-retinoic acid; D014212:Tretinoin; D000068877:Imatinib Mesylate; D011505:Protein-Tyrosine Kinases